Posted by Michael Wonder on 15 Jul 2017
Agenda for 19 July TC meeting
15 July 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Daratumumab (Darzalex)
- Arsenic trioxide (Trisenox)
- Cyclosporin (Ikervis)
- Mechlorethamine hydrochloride (Ledaga)
- Canakinumab (Ilaris)
- Penicillamine (Trololol)
